These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7948602)

  • 1. Resistance to cyclophosphamide-induced diabetes in transgenic NOD mice expressing I-Ak.
    Tashiro F; Kasuga A; Shimada A; Ishii M; Takei I; Miyazaki T; Yamamura K; Miyazaki J
    Autoimmunity; 1994; 17(3):181-8. PubMed ID: 7948602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete prevention of diabetes in transgenic NOD mice expressing I-E molecules.
    Uno M; Miyazaki T; Uehira M; Nishimoto H; Kimoto M; Miyazaki J; Yamamura K
    Immunol Lett; 1992 Jan; 31(1):47-52. PubMed ID: 1548033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
    Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
    J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
    J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
    Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
    J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
    Slattery RM; Kjer-Nielsen L; Allison J; Charlton B; Mandel TE; Miller JF
    Nature; 1990 Jun; 345(6277):724-6. PubMed ID: 1972779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells are unresponsive to transgenic MHC class II molecules expressed on pancreatic beta cells.
    Pilström B; Böhme J
    Scand J Immunol; 1997 Apr; 45(4):361-5. PubMed ID: 9105422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line.
    Wherrett DK; Singer SM; McDevitt HO
    Diabetes; 1997 Dec; 46(12):1970-4. PubMed ID: 9392482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
    Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T
    Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
    Schmidt D; Verdaguer J; Averill N; Santamaria P
    J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.
    La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N
    J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice.
    Prochazka M; Serreze DV; Frankel WN; Leiter EH
    Diabetes; 1992 Jan; 41(1):98-106. PubMed ID: 1727742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes.
    Slattery RM; Miller JF; Heath WR; Charlton B
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10808-10. PubMed ID: 7902572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules.
    Miyazaki T; Matsuda Y; Toyonaga T; Miyazaki J; Yazaki Y; Yamamura K
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9519-23. PubMed ID: 1409662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
    Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
    J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
    Balasa B; Lee J; Sarvetnick N
    Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus.
    Quartey-Papafio R; Lund T; Chandler P; Picard J; Ozegbe P; Day S; Hutchings PR; O'Reilly L; Kioussis D; Simpson E
    J Immunol; 1995 May; 154(10):5567-75. PubMed ID: 7730655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.